Forbes October 18, 2023
Topline
Pfizer will charge health insurers as much as $1,390 for a five-day course of its Covid-19 treatment Paxlovid, the company told multiple news outlets, a price that comes as the drug’s distribution changes hands from the federal government to Pfizer’s commercial business—and as Pfizer predicts lower revenue from its coronavirus products.
Key Facts
What To Watch For
Pfizer will offer a patient assistance program for uninsured people with HHS-procured Paxlovid from 2025 to 2028, HHS said last week. Pfizer will also run a copay assistance program for patients with commercial insurance through 2028.
Big Number
24 million. That’s the number of treatment courses for the pills purchased by the U.S. government for about $530 each, according to multiple reports.
...Today's Sponsors
Today's Sponsor